Back to search

University of Washington

Designing an Assay to Evaluate NBS Results Using Targeted Long-Read Sequencing

Abstract

dc:description.abstract

NBS (NBS) is a routine screening process that identifies selected genetic, metabolic, and endocrine disorders that can affect a newborn’s health. Unfortunately, limitations in the follow-up process can create barriers to confirming screening results. Here, we demonstrate the ability of targeted long-read sequencing (T-LRS) in evaluating NBS results. Using adaptive sampling on the Oxford Nanopore platform on 8 positive control samples from Seattle Children’s Hospital, we computationally targeted more than 500 genes relevant to metabolic and non-metabolic disorders and searched for pathogenic variants using a single data source. We detected all genomic variants identified by prior genetic testing, as well as additional variants not previously identified. T-LRS demonstrates to be an efficient and cost-effective method to evaluate individuals after a positive NBS result.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • YE, SHENYI
Advisors dc:contributor.advisor
  • Miller, Danny
  • Scott, Anna

Subjects

dc:subject × 2

Rights

dc:rights
Statement dc:rights
  • CC BY
Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/1773/53227

Chain of custody

source
Harvested from
University of Washington
Base URL
digital.lib.washington.edu/server/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

YE, SHENYI. Designing an Assay to Evaluate NBS Results Using Targeted Long-Read Sequencing. 2025. https://hdl.handle.net/1773/53227